CompletedPHASE2, PHASE3NCT00773292
Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Studying Tropical spastic paraparesis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Imperial College London
- Principal Investigator
- Graham P TaylorImperial College London
- Intervention
- ciclosporin(drug)
- Enrollment
- 7 target
- Eligibility
- 16-75 years · All sexes
- Timeline
- 2006 – 2010
Study locations (1)
- National Centre for Human Retrovirology, London, United Kingdom
Collaborators
Medical Research Council · University Hospital Birmingham · Imperial College Healthcare NHS Trust
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00773292 on ClinicalTrials.govOther trials for Tropical spastic paraparesis
Additional recruiting or active studies for the same condition.